These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 4936440)
61. Neuropathology of the cortical lesions of the Parkinsonian-dementia (PD) complex of Guam. Tan NT; Kakulas BA; Masters CL; Chen KM; Gibbs CJ; Gajdusek DC Clin Exp Neurol; 1981; 17():227-34. PubMed ID: 6286187 [TBL] [Abstract][Full Text] [Related]
62. [Catecholamine excretion and treatment of parkinsonism with midantan]. Kandel' EI; Iadgarov IS Zh Nevropatol Psikhiatr Im S S Korsakova; 1976 Sep; 76(9):1323-6. PubMed ID: 1015136 [No Abstract] [Full Text] [Related]
63. The effect of calcium on behavior and drug-induced extrapyramidalism. Yaryura-Tobias JA; White L; Diamond B; Merlis S Curr Ther Res Clin Exp; 1969 Nov; 11(11):677-80. PubMed ID: 4982302 [No Abstract] [Full Text] [Related]
64. [Combined treatment of Parkinsonism with levopa, midantan and anticholinergic drugs]. Evtushenko SK Zh Nevropatol Psikhiatr Im S S Korsakova; 1976 Dec; 76(12):1797-1802. PubMed ID: 1015115 [TBL] [Abstract][Full Text] [Related]
67. Constantin von Economo's contribution to the understanding of movement disorders. Ransmayr G Mov Disord; 2007 Mar; 22(4):469-75. PubMed ID: 17290463 [TBL] [Abstract][Full Text] [Related]
68. The fine structure of some intraganglionic alterations. Neurofibrillary tangles, granulovacuolar bodies and "rod-like" structures as seen in Guam amyotrophic lateral sclerosis and parkinsonism-dementia complex. Hirano A; Dembitzer HM; Kurland LT; Zimmerman HM J Neuropathol Exp Neurol; 1968 Apr; 27(2):167-82. PubMed ID: 5646193 [No Abstract] [Full Text] [Related]
69. [On muscular atrophies associated with postencephalitis parkinsonism]. HUFSCMIDT HJ; SCHALTENBRAND G; SOLCHER H Dtsch Z Nervenheilkd; 1960; 181():335-44. PubMed ID: 13716603 [No Abstract] [Full Text] [Related]
70. Postencephalitic parkinsonism responsive to a dopamine agonist: A case report. Kim R; Shin CW; Kim HJ; Jeon BS Parkinsonism Relat Disord; 2015 Jun; 21(6):667-8. PubMed ID: 25899543 [No Abstract] [Full Text] [Related]
71. [Experience with the use of parlodel in the treatment of Parkinson patients]. Stoliarova LG; Kadykov AS; Shvedkov VV; Pivovarova VM Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(2):219-22. PubMed ID: 3705825 [TBL] [Abstract][Full Text] [Related]
75. Lisuride in parkinsonism. Parkes JD; Schachter M; Marsden CD; Smith B; Wilson A Ann Neurol; 1981 Jan; 9(1):48-52. PubMed ID: 7212665 [TBL] [Abstract][Full Text] [Related]
76. [Postencephalitic parkinsonism]. Mori H Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):32-5. PubMed ID: 10434584 [No Abstract] [Full Text] [Related]
77. Drug-induced extrapyramidal symptoms: their incidence and treatment. Sheppard C; Merlis S Am J Psychiatry; 1967 Jan; 123(7):886-9. PubMed ID: 6016862 [No Abstract] [Full Text] [Related]
78. Nitric oxide, glial cells and neuronal degeneration in parkinsonism. Hirsch EC; Hunot S Trends Pharmacol Sci; 2000 May; 21(5):163-5. PubMed ID: 10785644 [No Abstract] [Full Text] [Related]
80. Relation between handedness and side of onset of Parkinsonism. Reynolds LM; Locke S Lancet; 1971 Sep; 2(7726):714. PubMed ID: 4105754 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]